These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3120304)

  • 1. In situ characterization of the cutaneous immune response in Ethiopian cutaneous leishmaniasis.
    Nilsen R; Mshana RN
    Scand J Immunol; 1987 Nov; 26(5):503-12. PubMed ID: 3120304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In situ characterization of the cellular immune response in American cutaneous leishmaniasis.
    Modlin RL; Tapia FJ; Bloom BR; Gallinoto ME; Castes M; Rondon AJ; Rea TH; Convit J
    Clin Exp Immunol; 1985 May; 60(2):241-8. PubMed ID: 3159527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adhesion molecules in lesions of American cutaneous leishmaniasis.
    Tapia FJ; Cáceres-Dittmar G; Sánchez MA; Fernández CT; Rondón AJ; Convit J
    Exp Dermatol; 1994 Feb; 3(1):17-22. PubMed ID: 7914808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intermediate or chronic cutaneous leishmaniasis: leukocyte immunophenotypes and cytokine characterisation of the lesion.
    Diaz NL; Zerpa O; Ponce LV; Convit J; Rondon AJ; Tapia FJ
    Exp Dermatol; 2002 Feb; 11(1):34-41. PubMed ID: 11952826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunopathology of American tegumentary leishmaniasis].
    Castés M; Tapia FJ
    Acta Cient Venez; 1998; 49(1):42-56. PubMed ID: 10205916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunocytochemical characterization of immune cells in lesions of American cutaneous leishmaniasis using novel T cell markers.
    Martínez-Arends A; Tapia FJ; Cáceres-Dittmar G; Mosca W; Valecillos L; Convit J
    Acta Trop; 1991 Sep; 49(4):271-80. PubMed ID: 1684261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal compromise in American cutaneous leishmaniasis.
    Cáceres-Dittmar G; Sánchez MA; Oriol O; Kraal G; Tapia FJ
    J Invest Dermatol; 1992 Nov; 99(5):95S-98S. PubMed ID: 1358984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Responsiveness in diffuse versus local cutaneous leishmaniasis is due to parasite differences.
    Akuffo H; Schurr E; Andersson G; Yamaneberhan T; Britton S
    Scand J Immunol; 1987 Dec; 26(6):717-21. PubMed ID: 3122314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cutaneous lesion in American leishmaniasis: leukocyte subsets, cellular interaction and cytokine production.
    Tapia FJ; Caceres-Dittmar G; Sanchez MA; Fernandez AE; Convit J
    Biol Res; 1993; 26(1-2):239-47. PubMed ID: 7545501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of the cytokine profile in American cutaneous leishmaniasis using the polymerase chain reaction.
    Cáceres-Dittmar G; Tapia FJ; Sánchez MA; Yamamura M; Uyemura K; Modlin RL; Bloom BR; Convit J
    Clin Exp Immunol; 1993 Mar; 91(3):500-5. PubMed ID: 8443970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell populations in the lesion of human cutaneous leishmaniasis: a light microscopical, immunohistochemical and ultrastructural study.
    Esterre P; Dedet JP; Frenay C; Chevallier M; Grimaud JA
    Virchows Arch A Pathol Anat Histopathol; 1992; 421(3):239-47. PubMed ID: 1413489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NK cell activity differs between patients with localized and diffuse cutaneous leishmaniasis infected with Leishmania mexicana: a comparative study of TLRs and cytokines.
    Cañeda-Guzmán IC; Salaiza-Suazo N; Fernández-Figueroa EA; Carrada-Figueroa G; Aguirre-García M; Becker I
    PLoS One; 2014; 9(11):e112410. PubMed ID: 25397678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunopathology of American cutaneous leishmaniasis. Modulation of MHC class II gene products by keratinocytes before and after glucantime therapy.
    Pirmez C; Oliveira-Neto MP; Grimaldi Júnior G; Savino W
    Mem Inst Oswaldo Cruz; 1990; 85(2):203-9. PubMed ID: 2128362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inducible nitric oxide synthase and cytokine pattern in lesions of patients with American cutaneous leishmaniasis.
    Díaz NL; Arveláez FA; Zerpa O; Tapia FJ
    Clin Exp Dermatol; 2006 Jan; 31(1):114-7. PubMed ID: 16309499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell subpopulations, expression of interleukin-2 receptor, and production of interleukin-2 and gamma interferon in human American cutaneous leishmaniasis.
    Castes M; Cabrera M; Trujillo D; Convit J
    J Clin Microbiol; 1988 Jun; 26(6):1207-13. PubMed ID: 3133391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell response to purified protein derivative after removal of Langerhans' cells from epidermal cell suspensions containing keratinocytes expressing class II transplantation antigens.
    Tjernlund U; Scheynius A; Johansson C; Hagforsen E; Nilsson H
    Scand J Immunol; 1988 Dec; 28(6):667-73. PubMed ID: 3266023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electron microscopical studies on cutaneous leishmaniasis in Ethiopia. II. Parasite and host cell differences between the localized and the diffuse form.
    Schurr E; Wunderlich F; Tadesse G
    Acta Trop; 1987 Dec; 44(4):395-407. PubMed ID: 2894130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunophenotypic analysis of the transformation zone of human cervix.
    Roncalli M; Sideri M; Giè P; Servida E
    Lab Invest; 1988 Feb; 58(2):141-9. PubMed ID: 2448545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allergic contact dermatitis: novel immunohistologic features.
    Wood GS; Volterra AS; Abel EA; Nickoloff BJ; Adams RM
    J Invest Dermatol; 1986 Dec; 87(6):688-93. PubMed ID: 2431068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperkeratosis lenticularis perstans (Flegel's disease). In situ characterization of T cell subsets and Langerhans' cells.
    Büchner SA
    Acta Derm Venereol; 1988; 68(4):341-5. PubMed ID: 2459881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.